Revisiting medullary tophi: A link between uric acid and progressive chronic kidney disease?

Clinical Nephrology

Volumn 85, Issue 2, 2016, Pages 109-113

  Ayoub, Isabelle ^a   Almaani, Salem ^a   Brodsky, Sergey ^b   Nadasdy, Tibor ^b   Prosek, Jason ^a   Hebert, Lee ^a   Rovin, Brad H ^a  

^a Division of Nephrology   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Hyperuricemia; Medullary tophi

Indexed keywords

CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HUMAN; HYPERURICEMIA; INFLAMMATION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDULLARY TOPHUS; MIDDLE AGED; NEPHRON; PREVALENCE; RETROSPECTIVE STUDY; URIC ACID BLOOD LEVEL; YOUNG ADULT; BIOPSY; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; KIDNEY COLLECTING TUBULE; KIDNEY MEDULLA; PATHOLOGY; PROCEDURES; RISK FACTOR; URINE;

ADULT; AGED; BIOPSY; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERURICEMIA; KIDNEY MEDULLA; KIDNEY TUBULES, COLLECTING; MALE; MIDDLE AGED; NEPHRONS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; URIC ACID; YOUNG ADULT;

EID: 84957868881     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108663     Document Type: Article

References (32)

1. Garrod AB. Nature and Treatment of Gout. Second edition. 618 pp. London: Walton and Maberly; 1863.
2. al-Awqati Q, Goldberg MR. Architectural patterns in branching morphogenesis in the kidney. Kidney Int. 1998; 54: 1832-1842.
3. Brown J, Mallory GK. Renal changes in gout. N Engl J Med. 1950; 243: 325-329.
4. Hench PS, Bauer W, et al. Rheumatism and arthritis; review of American and English literature of recent years. Ann Intern Med. 1948; 28: 66, passim.
5. Talbott JH. Gout. In: Oxford Loose-leaf Medicine. Vol. 4. Chap.4. New York: Oxford University Press, 1943. p. 79-130.
6. Minkowski O. Die Gicht. Vienna: A. Holder, 1903. p. 388.
7. Bell ET. Renal diseases. Philadelphia: Lea & Febiger, 1946. p. 434.
8. Hollingworth P, Scott JT, Burry HC. Nonarticular gout: hyperuricemia and tophus formation without gouty arthritis. Arthritis Rheum. 1983; 26: 98-101.
9. Verger D, Leroux-Robert C, Ganter P, Richet G. [Gouty tophi in the renal medulla in chronic uremia. Study of 17 cases discovered from among 62 autopsies]. Nephron. 1967; 4: 356-370.
10. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65: 386-392.
11. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes:predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006; 17: 1422-1428.
12. Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD, Pietrow P, Ekeruo W. Biochemical profile of stone-forming patients with diabetes mellitus. Urology. 2003; 61: 523-527.
13. Meydan N, Barutca S, Caliskan S, Camsari T. Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol. 2003; 37: 64-70.
14. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant. 2005; 20: 468-469.
15. Daudon M, Traxer O, Conort P, Lacour B, Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol. 2006; 17: 2026-2033.
16. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007; 2: 883-888.
17. Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013; 28: 2221-2228.
18. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CYC. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004; 65: 1422-1425.
19. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006; 48: 905-915.
20. Linnane JW, Burry AF, Emmerson BT. Urate deposits in the renal medulla. Prevalence and associations. Nephron. 1981; 29: 216-222.
21. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003; 348: 101-108.
22. Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl. 2005; 68 (s97): S68-S77.
23. SV P. Retarding Progression of Kidney Disease. In: Comprehensive Clinical Nephrology, edited by Floege J, Fehally J, Johnson RJ, 5th Edition, Elsevier, Philadelphia 2014, p. 931-947.
24. Beck LH. Requiem for gouty nephropathy. Kidney Int. 1986; 30: 280-287.
25. Nickeleit V, Mihatsch MJ. Uric acid nephropathy and end-stage renal disease - review of a non-disease. Nephrol Dial Transplant. 1997; 12: 1832-1838.
26. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006; 47: 51-59.
27. Gibson T, Rodgers V, Potter C, Simmonds HA. Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann Rheum Dis. 1982; 41: 59-65.
28. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010; 5: 1388-1393.
29. Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J. Allopurinol and progression of CKD and cardiovascular events: longterm follow-up of a randomized clinical trial. Am J Kidney Dis. 2015; 65: 543-549.
30. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008; 300: 924-932.
31. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006; 114: 2508-2516.
32. Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007; 27: 435-440.